Efficacy and Safety of Jiedu Tongluo Granules for Post-stroke Depression

Recruiting

Phase Early 1 Results N/A

Summary of Purpose

To explore the efficacy and safety of Jiedu Tongluo granules for post stroke depression. A randomized, double-blind, placebo-controlled clinical trial was designed. The treatment group was administered the Jiedu Tongluo granules, while the control group was administered the placebo.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 May 2017.

27 Apr 2017 1 May 2017 1 Dec 2017 1 Mar 2018 1 Apr 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts